Labshake search
Citations for Stemcell Technologies :
1 - 50 of 876 citations for Type 1 Angiotensin II Receptor AGTR1 Antibody since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Developmental Biology 2024Quote: ... and 2 µM A83-01, an inhibitor of TGFβ type I receptors (ALK4, ALK5, ALK7) (Stem Cell Technologies, 72022) for 5 days in vitro to induce embryoid body (EB ...
-
bioRxiv - Bioengineering 2023Quote: ... 1G4 PBMCs loaded onto pMHC nanovials were sorted based on calcein AM and NGFR signal and reconstituted with 0.75 mL media and 0.25 mL of 10 mg/mL Collagenase Type II solution (STEMCELL Technologies), followed by a 2 hour incubation at 37°C ...
-
bioRxiv - Neuroscience 2021Quote: ... 1 U/mL Dispase II (STEMCELL Technologies, 07913), 2.5 U/mL Papain (Worthington Biochemical ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 U/mL Dispase II (STEMCELL Technologies, 07913), 2.5 U/mL Papain (Worthington Biochemical ...
-
bioRxiv - Cell Biology 2023Quote: ... with StemSpan SFEM II containing 1% Penicillin Streptomycin and the StemSpan Myeloid Expansion Supplement II (StemCell Technologies). At day 15 ...
-
bioRxiv - Bioengineering 2023Quote: ... to 1 volume of CellAdhere™ type I bovine (STEMCELL Technologies, Cat# 07001) we added 8/10 volume of DMEM ...
-
bioRxiv - Immunology 2019Quote: ... Collagenase Type IV (STEMCELL Technologies, Catalog #07909); ROCKi ...
-
bioRxiv - Bioengineering 2022Quote: ... printed constructs were incubated for 20 min in 5 mg mL-1 collagenase type I (STEMCELL Technologies) in PBS supplemented with 5% FBS and then lysed with RLT buffer ...
-
bioRxiv - Cancer Biology 2022Quote: ... or StemSpan Serum Free Expansion Media II (SFEM II) (Stem Cell Technologies), supplemented with human stem cell factor (SCF ...
-
bioRxiv - Developmental Biology 2022Quote: ... Roughly separated tubules were incubated in collagenase type IV in DMEM (5 mL for 1 testis pair, 1 mg/mL, STEMCELL Technologies Inc., Cat# 07909) at 37 °C while rotating ...
-
bioRxiv - Bioengineering 2023Quote: ... 0.5 mg/ mL Collagenase Type IV (Stem Cell Technologies), 250 U/ mL Deoxyribonuclease I (Worthington Biochemical Corporation ...
-
bioRxiv - Bioengineering 2023Quote: ... 0.5 mg/mL Collagenase Type IV (Stem Cell Technologies), 250 U/mL Deoxyribonuclease I (Worthington Biochemical Corporation ...
-
Efficient Methods for Target Gene Manipulation in Haematopoietic Stem Cell Derived Human NeutrophilsbioRxiv - Cell Biology 2023Quote: ... 40% SFEM II (StemCell Technologies) and 10% DMSO (Sigma-Aldrich).
-
bioRxiv - Cell Biology 2021Quote: ... CD34+ cells (1 × 105/mL) were suspended in serum-free expansion medium II (Stem Cell Technologies) with 50 ng/mL stem cell factor (PeproTech ...
-
bioRxiv - Developmental Biology 2019Quote: ... embryos were treated with Collagenase Type I (Stemcell technologies; 07902) at 0,125% for 1h at 37º ...
-
bioRxiv - Developmental Biology 2022Quote: ... 10 μg/ml collagen type I (Stemcell Technologies, Catalog # 07001), 50 μg/ml penicillin/streptomycin ...
-
bioRxiv - Immunology 2022Quote: Splenic macrophages were magnetically labeled and isolated using StemCell EasySep PE Positive Selection Kit II in concert with an F4/80 PE-conjugated antibody (StemCell Technologies). Briefly ...
-
bioRxiv - Bioengineering 2024Quote: ... Cells were cultured in StemSpan™ Serum-Free Expansion Medium version II (SFEM II; STEMCELL Technologies) containing 50 ng/mL each of recombinant human stem cell factor (SCF ...
-
bioRxiv - Immunology 2021Quote: ... Selection kit II (STEMCELL Technologies, #17877) according to the manufacturer’s instructions ...
-
bioRxiv - Cancer Biology 2022Quote: ... StemSpan SFEM II (Stem Cell Technologies) supplemented with recombinant 50 ng/mL SCF and FLT3-L ...
-
bioRxiv - Bioengineering 2024Quote: ... containing StemSpan SFEM II (StemCell Technologies) supplemented with penicillin/streptomycin (100 U/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... Pellets were then suspended with 1 ml pre-warmed to 37°C A-mTE-D2 (7 mg ml-1 Dispase II, Worthington NPRO2, and 10 µg ml-1 Deoxyribonuclease I, Stem Cell Technologies, 07900), and mixed 70 times with a 1000 µl pipette tip ...
-
bioRxiv - Immunology 2020Quote: ... FcγRII or FcγRIII block was performed by addition of receptor specific mAbs (Stem cell technologies, IV.3 and 3G8) at a 1:100 dilution at the beginning of the incubation period ...
-
bioRxiv - Neuroscience 2023Quote: ... hiPSCs were dissociated with Collagenase Type IV (STEMCELL Technologies, Catlog #07909). Differentiation media contain growth factors and small molecule including SHH (100 ng/ml ...
-
bioRxiv - Molecular Biology 2023Quote: ... CD34+ HSPCs were cultured at 1×105 cells/mL in StemSpan Serum-Free Expansion Medium II (STEMCELL Technologies) or Good Manufacturing Practice Stem Cell Growth Medium (SCGM ...
-
bioRxiv - Genetics 2023Quote: ... 1 million cells were cultured for 8 days in StemSpanTM SFEM II medium (Stem Cell Technologies Catalog #09605) supplemented with 1X StemSpanTM Erythroid Expansion Supplement (Stem Cell Technologies Catalog #02692).
-
bioRxiv - Genetics 2022Quote: ... Anti-nestin mouse antibody (StemCell Technologies, 60091, 1:1000), Alexa Fluor 488-anti-Mouse (A11029 ...
-
bioRxiv - Bioengineering 2023Quote: ... CD31+ EPCs were purified using a FITC-conjugated human CD31 antibody (Miltenyi, cat# 130-117-390, clone AC128) and the EasySep Human FITC Positive Selection Kit II (Stemcell Technologies, cat# 18558). Purified EPCs were seeded into collagen IV (Sigma-Aldrich ...
-
bioRxiv - Developmental Biology 2020Quote: ... Dispase II (2.5 U/mL; STEMCELL Technologies), fatty acid free bovine serum albumin (2% ...
-
bioRxiv - Molecular Biology 2022Quote: ... 1U/ml Dispase II (STEMCELL Technologies, 07913), and 0.1mg/ml DNase I (Sigma ...
-
bioRxiv - Microbiology 2022Quote: ... 0.5 U/mL Dispase II (StemCell Technologies), and 50 μg/mL DNase (Alfa Aesar ...
-
bioRxiv - Systems Biology 2022Quote: ... Dispase II (2.5 U/mL; STEMCELL Technologies), fatty acid-free bovine serum albumin (2% ...
-
bioRxiv - Developmental Biology 2023Quote: ... StemSpan™ SFEM II (#09605, STEMCELL Technologies) supplemented with StemSpan™ Erythroid Expansion Supplement (100X ...
-
bioRxiv - Immunology 2020Quote: ... PBMCs were resuspended in SFEM II (StemCell Technologies) with 5 μg/mL purified anti-CD28 (clone CD28.2 ...
-
bioRxiv - Bioengineering 2023Quote: Bone marrow-derived human CD34+ stem cells were purchased from Stemcell technologies and cultured in SFEM II medium (Stemcell technologies) containing 100 μM SCF (Stemcell technologies ...
-
bioRxiv - Bioengineering 2024Quote: ... and 1X Myeloid Expansion Supplement II (StemCell Technologies). Cells were maintained for up to three weeks in the same plates and split every three to four days by discarding 160 μL of medium and adding 160 μL of fresh differentiation medium to each well.
-
bioRxiv - Cancer Biology 2022Quote: ... The t(8;21)-positive patient primary cells were co-cultured on MSCs feeders and cultivated with SFEM II containing 1X Human Myeloid Expansion Supplement II (StemCell Technologies).
-
bioRxiv - Genetics 2022Quote: ... HSPCs were transferred into erythroid differentiation medium (EDM) consisting of StemSpan serum-free expansion medium II(SFEM II; Stem Cell Technologies) with 1% penicillin/streptomycin (Thermo Fisher Scientific) ...
-
bioRxiv - Immunology 2019Quote: Cord blood CD34+ hematopoietic stem cells were purchased and cultured in StemSpan II media with the MK supplemental cytokines (StemSpan II, Stemcell Technologies, Inc.), according to the culture and differentiation protocols from Stemcell Technologies (Stemcell Technologies Inc ...
-
bioRxiv - Immunology 2024Quote: ... Macrophages were differentiated from the expanded CD34+ cells by first culturing for 7 days in StemSpan SFEM II supplemented with StemSpan Myeloid Expansion Supplement II (StemCell Tech 02694), and then culturing for another 7 days in IMDM media containing 20 ng/mL MCSF (PeproTech ...
-
bioRxiv - Cell Biology 2020Quote: ... cells were dissociated in collagenase type IV followed by Accutase (Stemcell Technologies, BC, Canada) and the fragmented cells were passaged to a new collagen-coated plate.
-
bioRxiv - Cell Biology 2019Quote: ... in 2 ml of SFEM II (Stem Cell Technologies) supplemented with 10 ng ml−1 IL3 ...
-
bioRxiv - Immunology 2021Quote: ... the EasySep Biotin Positive Selection Kit II (Stemcell Technologies), and biotinylated anti-mouse CD49b antibody (25 µg/ 1×108 via.cells ...
-
bioRxiv - Cell Biology 2020Quote: ... and cultured in SFEM II medium (StemCell Technologies, 09605) supplemented with CD34+ Expansion Supplement (StemCell Technologies ...
-
bioRxiv - Cancer Biology 2023Quote: ... were cultured in StemSpan SFEM II (STEMCELL Technologies, #09605), 100 U/mL Penicillin and 100 μg/mL Streptomycin supplemented with 10 ng/mL human recombinant TPO ...
-
bioRxiv - Immunology 2023Quote: ... and EasySep APC Positive Selection Kit II (StemCell Technologies) following manufacturers recommendations.
-
bioRxiv - Immunology 2023Quote: ... and EasySep APC Positive Selection Kit II (StemCell Technologies) following manufacturers recommendations.
-
bioRxiv - Developmental Biology 2023Quote: ... and 15 U/ml Dispase II (Stemcell Technologies, 7913) in HBSS) ...
-
bioRxiv - Immunology 2023Quote: ... The EasySep PE Positive Selection Kit II (StemCell Technologies) and MojoSort Magnets (BioLegend ...
-
bioRxiv - Developmental Biology 2023Quote: ... and 15 U/ml Dispase II (Stemcell Technologies, 7913) in HBSS) ...